Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Cook MB"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 33
Tytuł:
Successful Renal Outcome in Membranoproliferative Glomerulonephritis Following Treatment of the Underlying Subtle Clone: A Case Report
Autorzy:
Ritika Rana, MBBS, MRCP
Paul Cockwell, MB BCh, FRCP, PhD
Bindu Vydianath, MBBS, FRCPath
Mark Cook, MB ChB, PhD
Guy Pratt, FRCP, FRCPath, MD
Mark Trehane Drayson, FRCPath, PhD
Jennifer Helen Pinney, BM BS, MD
Pokaż więcej
Temat:
Medicine (General)
R5-920
Źródło:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 2, Iss 3, Pp 297-302 (2018)
Opis pliku:
electronic resource
Relacje:
http://www.sciencedirect.com/science/article/pii/S254245481830033X; https://doaj.org/toc/2542-4548
Dostęp URL:
https://doaj.org/article/e3e64adb0af343e88ac36def145138b8  Link otwiera się w nowym oknie
Czasopismo naukowe
Szczegóły
Tytuł:
Applying recommended definition of aggressive prostate cancer: a validation study using high-quality data from the Cancer Registry of Norway.
Autorzy:
Robsahm TE; Department of Research, Cancer Registry of Norway, Oslo, Norway.
Tsuruda KM; Department of Research, Cancer Registry of Norway, Oslo, Norway.
Hektoen HH; Department of Research, Cancer Registry of Norway, Oslo, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
Storås AH; Department of Research, Cancer Registry of Norway, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway.
Cook MB; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Hurwitz LM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Langseth H; Department of Research, Cancer Registry of Norway, Oslo, Norway.; Department of Epidemiology and Biostatistics, Imperial College London, London, UK.
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Jan; Vol. 62 (1), pp. 8-14. Date of Electronic Publication: 2023 Feb 10.
Typ publikacji:
Journal Article
MeSH Terms:
Prostatic Neoplasms*/diagnosis
Prostatic Neoplasms*/epidemiology
Male ; Humans ; Prostate/pathology ; Prostate-Specific Antigen ; Neoplasm Grading ; Registries
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Urinary PGE-M in Men with Prostate Cancer.
Autorzy:
Kiely M; Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Milne GL; Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Minas TZ; Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Dorsey TH; Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Tang W; Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Smith CJ; Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Baker F; Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Loffredo CA; Cancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20007, USA.
Yates C; Center for Cancer Research, Department of Biology, Tuskegee University, Tuskegee, AL 36088, USA.
Cook MB; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20850, USA.
Ambs S; Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Aug 13; Vol. 13 (16). Date of Electronic Publication: 2021 Aug 13.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Fatherhood status in relation to prostate cancer risks in two large U.S.-based prospective cohort studies.
Autorzy:
Geczik AM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
Kelly SP; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
Pfeiffer RM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
Huang WY; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
Liao LM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
Zhou CK; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
Brinton LA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
Cook MB; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2021 Jan; Vol. 10 (1), pp. 405-415. Date of Electronic Publication: 2020 Nov 21.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Fathers*
Fertility*
Prostatic Neoplasms/*epidemiology
Aged ; Family Characteristics ; Humans ; Incidence ; Male ; Middle Aged ; Prostatic Neoplasms/diagnosis ; Prostatic Neoplasms/mortality ; Risk Assessment ; Risk Factors ; United States/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Associations between circulating sex steroid hormones and leukocyte telomere length in men in the National Health and Nutrition Examination Survey.
Autorzy:
Coburn SB; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
Graubard BI; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
Trabert B; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
McGlynn KA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
Cook MB; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
Pokaż więcej
Źródło:
Andrology [Andrology] 2018 Jul; Vol. 6 (4), pp. 542-546. Date of Electronic Publication: 2018 May 11.
Typ publikacji:
Journal Article; Research Support, N.I.H., Intramural
MeSH Terms:
Gonadal Steroid Hormones/*blood
Telomere/*metabolism
Telomere Homeostasis/*physiology
Adult ; Aged ; Cross-Sectional Studies ; Humans ; Leukocytes/metabolism ; Male ; Middle Aged ; Nutrition Surveys ; Sex Hormone-Binding Globulin/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Association between circulating levels of sex steroid hormones and esophageal adenocarcinoma in the FINBAR Study.
Autorzy:
Petrick JL; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, Maryland, United States of America.
Falk RT; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, Maryland, United States of America.
Hyland PL; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, Maryland, United States of America.
Caron P; Pharmacogenomics Laboratory, Centre Hospitalier de l'Université Laval de Québec (CHU de Québec) Research Center and Faculty of Pharmacy, Laval University, Québec City, Québec, Canada.
Pfeiffer RM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, Maryland, United States of America.
Wood SN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, Maryland, United States of America.
Dawsey SM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, Maryland, United States of America.
Abnet CC; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, Maryland, United States of America.
Taylor PR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, Maryland, United States of America.
Guillemette C; Pharmacogenomics Laboratory, Centre Hospitalier de l'Université Laval de Québec (CHU de Québec) Research Center and Faculty of Pharmacy, Laval University, Québec City, Québec, Canada.
Murray LJ; Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queens University Belfast, Belfast, Northern Ireland, United Kingdom.
Anderson LA; Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queens University Belfast, Belfast, Northern Ireland, United Kingdom.
Cook MB; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, Maryland, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2018 Jan 17; Vol. 13 (1), pp. e0190325. Date of Electronic Publication: 2018 Jan 17 (Print Publication: 2018).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Adenocarcinoma/*blood
Esophageal Neoplasms/*blood
Gonadal Steroid Hormones/*blood
Female ; Humans ; Male
SCR Disease Name:
Adenocarcinoma Of Esophagus
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 men.
Autorzy:
Watts EL; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Appleby PN; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Albanes D; Division of Cancer Epidemiology and Genetics, U.S. National Cancer Institute, Bethesda, MD, United States of America.
Black A; Division of Cancer Epidemiology and Genetics, U.S. National Cancer Institute, Bethesda, MD, United States of America.
Chan JM; Department of Epidemiology and Biostatistics, University of California-San Francisco, San Francisco, CA, United States of America.; Department of Urology, University of California-San Francisco, San Francisco, CA, United States of America.
Chen C; Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
Cirillo PM; Child Health and Development Studies, Public Health Institute, Berkeley, CA, United States of America.
Cohn BA; Child Health and Development Studies, Public Health Institute, Berkeley, CA, United States of America.
Cook MB; Division of Cancer Epidemiology and Genetics, U.S. National Cancer Institute, Bethesda, MD, United States of America.
Donovan JL; School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.
Ferrucci L; Intramural Research Program, National Institute on Aging, Bethesda, MD, United States of America.
Garland CF; Department of Family Medicine and Public Health, University of California, San Diego, CA, United States of America.
Giles GG; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Victoria, Australia.
Goodman PJ; SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
Habel LA; Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States of America.
Haiman CA; Department of Preventive Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America.
Holly JMP; School of Clinical Sciences, Faculty of Health Science, University of Bristol, Bristol, United Kingdom.
Hoover RN; Division of Cancer Epidemiology and Genetics, U.S. National Cancer Institute, Bethesda, MD, United States of America.
Kaaks R; Division of Cancer Epidemiology, German Cancer Research Centre, Heidelberg, Germany.
Knekt P; Department of Health, National Institute for Health and Welfare, Helsinki, Finland.
Kolonel LN; University of Hawaii Cancer Center, University of Hawaii, Honolulu, HI, United States of America.
Kubo T; Department of Public Health, University of Occupational and Environmental Health, Kitakyushu, Japan.
Le Marchand L; University of Hawaii Cancer Center, University of Hawaii, Honolulu, HI, United States of America.
Luostarinen T; Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland.
MacInnis RJ; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Victoria, Australia.
Mäenpää HO; Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland.
Männistö S; Department of Health, National Institute for Health and Welfare, Helsinki, Finland.
Metter EJ; Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, United States of America.
Milne RL; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Victoria, Australia.
Nomura AMY; Japan-Hawaii Cancer Study, Kuakini Medical Center, Honolulu, HI, United States of America.
Oliver SE; Department of Health Sciences, University of York, York, United Kingdom.
Parsons JK; Division of Urologic Oncology, University of California San Diego Moores Cancer Center, San Diego, CA, United States of America.
Peeters PH; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Netherlands.; MRC-PHE Centre for Environment and Health, Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, United Kingdom.
Platz EA; Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States of America.
Riboli E; School of Public Health, Imperial College London, London, United Kingdom.
Ricceri F; Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy.; Unit of Epidemiology, Regional Health Service ASL TO3, Grugliasco, Italy.
Rinaldi S; Biomarkers Group, International Agency for Research on Cancer, Lyon, France.
Rissanen H; Department of Health, National Institute for Health and Welfare, Helsinki, Finland.
Sawada N; Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
Schaefer CA; Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States of America.
Schenk JM; Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
Stanczyk FZ; Division of Reproductive Endocrinology and Infertility, Keck School of Medicine of the University of Southern California, Los Angeles, CA, United States of America.
Stampfer M; Departments of Nutrition and Epidemiology, Harvard University T.H. Chan School of Public Health, Boston, MA, United States of America.; The Channing Division of Network Medicine, Harvard Medical School, Boston, MA, United States of America.
Stattin P; Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden.
Stenman UH; Department of Clinical Chemistry, Medicum, University of Helsinki, Helsinki, Finland.
Tjønneland A; Department of Diet, Genes and Environment, The Danish Cancer Society Research Center, Copenhagen, Denmark.
Trichopoulou A; Hellenic Health Foundation, Athens, Greece.; WHO Collaborating Center for Nutrition and Health, Unit of Nutritional Epidemiology and Nutrition in Public Health, Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Greece.
Thompson IM; CHRISTUS Medical Center Hospital, San Antonio, TX, United States of America.
Tsugane S; Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
Vatten L; Department of Public Health, Norwegian University of Science and Technology, Trondheim, Norway.
Whittemore AS; Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA, United States of America.; Department of Biomedical Data Science, Stanford University, Stanford, CA, United States of America.
Ziegler RG; Division of Cancer Epidemiology and Genetics, U.S. National Cancer Institute, Bethesda, MD, United States of America.
Allen NE; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Key TJ; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Travis RC; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2017 Dec 27; Vol. 12 (12), pp. e0187741. Date of Electronic Publication: 2017 Dec 27 (Print Publication: 2017).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Anthropometry*
Behavior*
Datasets as Topic*
Social Class*
Gonadal Steroid Hormones/*blood
Adult ; Humans ; Male ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Marijuana use and serum testosterone concentrations among U.S. males.
Autorzy:
Thistle JE; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.
Graubard BI; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.
Braunlin M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.
Vesper H; National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Trabert B; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.
Cook MB; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.
McGlynn KA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.
Pokaż więcej
Źródło:
Andrology [Andrology] 2017 Jul; Vol. 5 (4), pp. 732-738. Date of Electronic Publication: 2017 Apr 10.
Typ publikacji:
Journal Article; Research Support, N.I.H., Intramural
MeSH Terms:
Marijuana Abuse/*blood
Marijuana Smoking/*blood
Testosterone/*blood
Adult ; Chromatography, Liquid ; Cross-Sectional Studies ; Health Status ; Humans ; Least-Squares Analysis ; Linear Models ; Male ; Middle Aged ; Multivariate Analysis ; Nutrition Surveys ; Radioisotope Dilution Technique ; Surveys and Questionnaires ; Tandem Mass Spectrometry ; Time Factors ; United States ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Sex steroid hormones in relation to Barrett's esophagus: an analysis of the FINBAR Study.
Autorzy:
Cook MB; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
Wood S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
Hyland PL; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
Caron P; Pharmacogenomics Laboratory, Centre Hospitalier de l'Université Laval de Québec (CHU de Québec) Research Center and Faculty of Pharmacy, Laval University, Quebec City, QC, Canada.
Drahos J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
Falk RT; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
Pfeiffer RM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
Dawsey SM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
Abnet CC; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
Taylor PR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
Guillemette C; Pharmacogenomics Laboratory, Centre Hospitalier de l'Université Laval de Québec (CHU de Québec) Research Center and Faculty of Pharmacy, Laval University, Quebec City, QC, Canada.
Murray LJ; Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queens University Belfast, Belfast, Northern Ireland.
Anderson LA; Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queens University Belfast, Belfast, Northern Ireland.
Pokaż więcej
Źródło:
Andrology [Andrology] 2017 Mar; Vol. 5 (2), pp. 240-247. Date of Electronic Publication: 2017 Feb 27.
Typ publikacji:
Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Barrett Esophagus/*blood
Dihydrotestosterone/*blood
Estradiol/*blood
Sex Hormone-Binding Globulin/*metabolism
Testosterone/*blood
Age Factors ; Aged ; Body Mass Index ; Enzyme-Linked Immunosorbent Assay ; Humans ; Male ; Mass Spectrometry ; Middle Aged ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Childhood body mass index in relation to future risk of oesophageal adenocarcinoma.
Autorzy:
Cook MB; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
Freedman ND; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
Gamborg M; Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospital, The Capital Region, Copenhagen, Denmark.
Sørensen TI; 1] Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospital, The Capital Region, Copenhagen, Denmark [2] The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Baker JL; 1] Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospital, The Capital Region, Copenhagen, Denmark [2] The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Pokaż więcej
Źródło:
British journal of cancer [Br J Cancer] 2015 Feb 03; Vol. 112 (3), pp. 601-7. Date of Electronic Publication: 2015 Jan 06.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Body Mass Index*
Adenocarcinoma/*epidemiology
Child Development/*physiology
Esophageal Neoplasms/*epidemiology
Adolescent ; Adult ; Age Factors ; Aged ; Child ; Child, Preschool ; Female ; Humans ; Male ; Middle Aged ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.
Autorzy:
Al Olama AA; 1] Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. [2].
Kote-Jarai Z; 1] Institute of Cancer Research, London, UK. [2].
Berndt SI; Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institute of Health, Bethesda, Maryland, USA.
Conti DV; 1] Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA. [2] Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California, USA.
Schumacher F; 1] Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA. [2] Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California, USA.
Han Y; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Benlloch S; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Hazelett DJ; 1] Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA. [2] Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California, USA.
Wang Z; 1] Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institute of Health, Bethesda, Maryland, USA. [2] Cancer Genomics Research Laboratory, National Cancer Institute, Division of Cancer Epidemiology and Genetics, SAIC-Frederick, Inc., Frederick, Maryland, USA.
Saunders E; Institute of Cancer Research, London, UK.
Leongamornlert D; Institute of Cancer Research, London, UK.
Lindstrom S; Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA.
Jugurnauth-Little S; Institute of Cancer Research, London, UK.
Dadaev T; Institute of Cancer Research, London, UK.
Tymrakiewicz M; Institute of Cancer Research, London, UK.
Stram DO; 1] Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA. [2] Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California, USA.
Rand K; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Wan P; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Stram A; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Sheng X; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Pooler LC; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Park K; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Xia L; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Tyrer J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Kolonel LN; Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.
Le Marchand L; Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.
Hoover RN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institute of Health, Bethesda, Maryland, USA.
Machiela MJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institute of Health, Bethesda, Maryland, USA.
Yeager M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institute of Health, Bethesda, Maryland, USA.
Burdette L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institute of Health, Bethesda, Maryland, USA.
Chung CC; Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institute of Health, Bethesda, Maryland, USA.
Hutchinson A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institute of Health, Bethesda, Maryland, USA.
Yu K; Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institute of Health, Bethesda, Maryland, USA.
Goh C; Institute of Cancer Research, London, UK.
Ahmed M; Institute of Cancer Research, London, UK.
Govindasami K; Institute of Cancer Research, London, UK.
Guy M; Institute of Cancer Research, London, UK.
Tammela TL; Department of Urology, Tampere University Hospital and Medical School, University of Tampere, Tampere, Finland.
Auvinen A; Department of Epidemiology, School of Health Sciences, University of Tampere, Tampere, Finland.
Wahlfors T; BioMediTech, University of Tampere and FimLab Laboratories, Tampere, Finland.
Schleutker J; 1] BioMediTech, University of Tampere and FimLab Laboratories, Tampere, Finland. [2] Department of Medical Biochemistry, Institute of Biomedicine, University of Turku, Turku, Finland.
Visakorpi T; Institute of Biomedical Technology/BioMediTech, University of Tampere and Tampere University Hospital, Tampere, Finland.
Leinonen KA; Institute of Biomedical Technology/BioMediTech, University of Tampere and Tampere University Hospital, Tampere, Finland.
Xu J; Center for Cancer Genomics, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Aly M; 1] Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden. [2] Department of Clinical Sciences at Danderyds Hospital, Stockholm, Sweden.
Donovan J; School of Social and Community Medicine, University of Bristol, Bristol, UK.
Travis RC; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Key TJ; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Siddiq A; Department of Genomics of Common Disease, School of Public Health, Imperial College London, London, UK.
Canzian F; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Khaw KT; Clinical Gerontology Unit, University of Cambridge, Cambridge, UK.
Takahashi A; Laboratory for Statistical Analysis, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Kubo M; Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Pharoah P; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Pashayan N; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Weischer M; Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark.
Nordestgaard BG; 1] Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark. [2] Faculty of Healthy and Medical Sciences, University of Copenhagen, Herlev, Denmark.
Nielsen SF; 1] Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark. [2] Faculty of Healthy and Medical Sciences, University of Copenhagen, Herlev, Denmark.
Klarskov P; Department of Urology, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark.
Røder MA; Copenhagen Prostate Cancer Center, Department of Urology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Iversen P; Copenhagen Prostate Cancer Center, Department of Urology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Thibodeau SN; Mayo Clinic, Rochester, Minnesota, USA.
McDonnell SK; Mayo Clinic, Rochester, Minnesota, USA.
Schaid DJ; Mayo Clinic, Rochester, Minnesota, USA.
Stanford JL; 1] Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. [2] Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington, USA.
Kolb S; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Holt S; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Knudsen B; Translational Pathology, Cedars-Sinai, Los Angeles, California, USA.
Coll AH; Prostate Center, Vancouver, British Columbia, Canada.
Gapstur SM; Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, USA.
Diver WR; Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, USA.
Stevens VL; Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, USA.
Maier C; Department of Urology, University Hospital Ulm, Ulm, Germany.
Luedeke M; Department of Urology, University Hospital Ulm, Ulm, Germany.
Herkommer K; Department of Urology, Klinikum Rechts der Isar der Technischen Universität München, Munich, Germany.
Rinckleb AE; Department of Urology, University Hospital Ulm, Ulm, Germany.
Strom SS; Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Pettaway C; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Yeboah ED; 1] University of Ghana Medical School, Accra, Ghana. [2] Korle Bu Teaching Hospital, Accra, Ghana.
Tettey Y; 1] University of Ghana Medical School, Accra, Ghana. [2] Korle Bu Teaching Hospital, Accra, Ghana.
Biritwum RB; 1] University of Ghana Medical School, Accra, Ghana. [2] Korle Bu Teaching Hospital, Accra, Ghana.
Adjei AA; 1] University of Ghana Medical School, Accra, Ghana. [2] Korle Bu Teaching Hospital, Accra, Ghana.
Tay E; 1] University of Ghana Medical School, Accra, Ghana. [2] Korle Bu Teaching Hospital, Accra, Ghana.
Truelove A; Westat, Rockville, Maryland, USA.
Niwa S; Westat, Rockville, Maryland, USA.
Chokkalingam AP; School of Public Health, University of California, Berkeley, Berkeley, California, USA.
Cannon-Albright L; 1] Division of Genetic Epidemiology, Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA. [2] George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, Utah, USA.
Cybulski C; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Wokołorczyk D; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Kluźniak W; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Park J; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA.
Sellers T; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA.
Lin HY; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida, USA.
Isaacs WB; James Buchanan Brady Urological Institute, Johns Hopkins Hospital and Medical Institution, Baltimore, Maryland, USA.
Partin AW; James Buchanan Brady Urological Institute, Johns Hopkins Hospital and Medical Institution, Baltimore, Maryland, USA.
Brenner H; 1] Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. [2] German Cancer Consortium, Heidelberg, Germany.
Dieffenbach AK; 1] Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. [2] German Cancer Consortium, Heidelberg, Germany.
Stegmaier C; Saarland Cancer Registry, Saarbrücken, Germany.
Chen C; Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA.
Giovannucci EL; 1] Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA. [2] Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA.
Ma J; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Stampfer M; 1] Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA. [2] Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA. [3] Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Penney KL; 1] Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA. [2] Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Mucci L; 1] Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA. [2] Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
John EM; 1] Cancer Prevention Institute of California, Fremont, California, USA. [2] Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA.
Ingles SA; 1] Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA. [2] Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California, USA.
Kittles RA; Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
Murphy AB; Department of Urology, Northwestern University, Chicago, Illinois, USA.
Pandha H; Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.
Michael A; Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.
Kierzek AM; Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.
Blot W; 1] International Epidemiology Institute, Rockville, Maryland, USA. [2] Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Signorello LB; 1] Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA. [2] Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Zheng W; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Albanes D; Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institute of Health, Bethesda, Maryland, USA.
Virtamo J; Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland.
Weinstein S; Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institute of Health, Bethesda, Maryland, USA.
Nemesure B; Department of Preventive Medicine, Stony Brook University, Stony Brook, New York, USA.
Carpten J; Translational Genomics Research Institute, Phoenix, Arizona, USA.
Leske C; Department of Preventive Medicine, Stony Brook University, Stony Brook, New York, USA.
Wu SY; Department of Preventive Medicine, Stony Brook University, Stony Brook, New York, USA.
Hennis A; 1] Department of Preventive Medicine, Stony Brook University, Stony Brook, New York, USA. [2] Chronic Disease Research Centre, University of the West Indies, Bridgetown, Barbados.
Kibel AS; Division of Urologic Surgery, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Rybicki BA; Department of Public Health Sciences, Henry Ford Hospital, Detroit, Michigan, USA.
Neslund-Dudas C; Department of Public Health Sciences, Henry Ford Hospital, Detroit, Michigan, USA.
Hsing AW; 1] Cancer Prevention Institute of California, Fremont, California, USA. [2] Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA.
Chu L; 1] Cancer Prevention Institute of California, Fremont, California, USA. [2] Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA.
Goodman PJ; Southwest Oncology Group Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Klein EA; Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Zheng SL; Center for Cancer Genomics, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Batra J; Australian Prostate Cancer Research Centre-Queensland, Institute of Health and Biomedical Innovation and School of Biomedical Science, Queensland University of Technology, Translational Research Institute, Brisbane, Queensland, Australia.
Clements J; Australian Prostate Cancer Research Centre-Queensland, Institute of Health and Biomedical Innovation and School of Biomedical Science, Queensland University of Technology, Translational Research Institute, Brisbane, Queensland, Australia.
Spurdle A; Molecular Cancer Epidemiology Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Teixeira MR; 1] Department of Genetics, Portuguese Oncology Institute, Porto, Portugal. [2] Biomedical Sciences Institute, University of Porto, Porto, Portugal.
Paulo P; Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.
Maia S; Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.
Slavov C; Department of Urology, Medical University-Sofia, Sofia, Bulgaria.
Kaneva R; Department of Medical Chemistry and Biochemistry, Molecular Medicine Center, Medical University-Sofia, Sofia, Bulgaria.
Mitev V; Department of Medical Chemistry and Biochemistry, Molecular Medicine Center, Medical University-Sofia, Sofia, Bulgaria.
Witte JS; 1] Institute for Human Genetics, University of California, San Francisco, San Francisco, California, USA. [2] Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.
Casey G; 1] Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA. [2] Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California, USA.
Gillanders EM; Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland, USA.
Seminara D; Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland, USA.
Riboli E; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Hamdy FC; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
Coetzee GA; 1] Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA. [2] Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California, USA.
Li Q; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Hunter DJ; Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA.
Muir K; 1] Institute of Population Health, University of Manchester, Manchester, UK. [2] Warwick Medical School, University of Warwick, Coventry, UK.
Gronberg H; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
Neal DE; 1] Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK. [2] Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
Southey M; Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, Victoria, Australia.
Giles GG; 1] Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia. [2] Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.
Severi G; 1] Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia. [2] Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia. [3] Human Genetics Foundation, Torino, Italy.
Cook MB; 1] Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institute of Health, Bethesda, Maryland, USA. [2].
Nakagawa H; 1] Laboratory for Genome Sequencing Analysis, RIKEN Center for Integrative Medical Sciences, Tokyo, Japan. [2].
Wiklund F; 1] Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden. [2].
Kraft P; 1] Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA. [2] Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, USA. [3].
Chanock SJ; 1] Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institute of Health, Bethesda, Maryland, USA. [2].
Henderson BE; 1] Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA. [2] Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California, USA. [3].
Easton DF; 1] Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. [2].
Eeles RA; 1] Institute of Cancer Research, London, UK. [2] Royal Marsden National Health Service (NHS) Foundation Trust, London and Sutton, UK. [3].
Haiman CA; 1] Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA. [2] Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California, USA. [3].
Pokaż więcej
Corporate Authors:
Breast and Prostate Cancer Cohort Consortium (BPC3)
PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium
COGS (Collaborative Oncological Gene-environment Study) Consortium
GAME-ON/ELLIPSE Consortium
Źródło:
Nature genetics [Nat Genet] 2014 Oct; Vol. 46 (10), pp. 1103-9. Date of Electronic Publication: 2014 Sep 14.
Typ publikacji:
Journal Article; Meta-Analysis
MeSH Terms:
Polymorphism, Single Nucleotide*
Genetic Loci/*genetics
Genetic Predisposition to Disease/*genetics
Prostatic Neoplasms/*genetics
Genome-Wide Association Study ; Genotype ; Humans ; Male ; Risk Assessment ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Gastroesophageal reflux in relation to adenocarcinomas of the esophagus: a pooled analysis from the Barrett's and Esophageal Adenocarcinoma Consortium (BEACON).
Autorzy:
Cook MB; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, Maryland, United States of America.
Corley DA; Division of Research and Oakland Medical Center, Kaiser Permanente, Northern California, Oakland, California, United States of America.
Murray LJ; Centre for Public Health, Queen's University, Belfast, Northern Ireland.
Liao LM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, Maryland, United States of America.
Kamangar F; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, Maryland, United States of America; Department of Public Health Analysis, School of Community Health and Policy, Morgan State University, Baltimore, Maryland, United States of America.
Ye W; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Gammon MD; Department of Epidemiology, University of North Carolina School of Public Health, Chapel Hill, North Carolina, United States of America.
Risch HA; Yale University School of Medicine, Department of Epidemiology and Public Health, New Haven, Connecticut, United States of America.
Casson AG; Department of Surgery, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Freedman ND; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, Maryland, United States of America.
Chow WH; The University of Texas MD Anderson Cancer Center, Department of Epidemiology, Houston, Texas, United States of America.
Wu AH; Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, California, United States of America.
Bernstein L; Department of Population Sciences, Beckman Research Institute and City of Hope Comprehensive Cancer Center, Duarte, California, United States of America.
Nyrén O; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Pandeya N; QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Whiteman DC; QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Vaughan TL; Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2014 Jul 30; Vol. 9 (7), pp. e103508. Date of Electronic Publication: 2014 Jul 30 (Print Publication: 2014).
Typ publikacji:
Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Adenocarcinoma/*etiology
Esophageal Neoplasms/*etiology
Gastroesophageal Reflux/*epidemiology
Age Factors ; Aged ; Body Mass Index ; Case-Control Studies ; Female ; Gastroesophageal Reflux/complications ; Humans ; Logistic Models ; Male ; Middle Aged ; Odds Ratio ; Risk Factors ; Smoking
SCR Disease Name:
Adenocarcinoma Of Esophagus
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Childhood body mass index and the risk of prostate cancer in adult men.
Autorzy:
Aarestrup J; Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospital, The Capital Region, Nordre Fasanvej 5, Frederiksberg, 2000 Copenhagen, Denmark.
Gamborg M; Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospital, The Capital Region, Nordre Fasanvej 5, Frederiksberg, 2000 Copenhagen, Denmark.
Cook MB; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, 9609 Medical Center Drive, Room 7-E106, MSC 9774, Bethesda, MD 20892-9774, USA.
Sørensen TI; 1] Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospital, The Capital Region, Nordre Fasanvej 5, Frederiksberg, 2000 Copenhagen, Denmark [2] Novo Nordisk Foundation Center for Basic Metabolic Research, Section on Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen 1, 1. Floor, 2100 Copenhagen, Denmark.
Baker JL; 1] Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospital, The Capital Region, Nordre Fasanvej 5, Frederiksberg, 2000 Copenhagen, Denmark [2] Novo Nordisk Foundation Center for Basic Metabolic Research, Section on Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen 1, 1. Floor, 2100 Copenhagen, Denmark.
Pokaż więcej
Źródło:
British journal of cancer [Br J Cancer] 2014 Jul 08; Vol. 111 (1), pp. 207-12. Date of Electronic Publication: 2014 May 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Body Mass Index*
Prostatic Neoplasms/*epidemiology
Adolescent ; Adult ; Child ; Cohort Studies ; Denmark/epidemiology ; Humans ; Incidence ; Male ; Obesity/epidemiology ; Risk Factors ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men.
Autorzy:
Finkle WD; Consolidated Research, Inc., Los Angeles, California, United States of America.
Greenland S; Department of Epidemiology and Department of Statistics, University of California, Los Angeles, California, United States of America.
Ridgeway GK; Consolidated Research, Inc., Los Angeles, California, United States of America.
Adams JL; Consolidated Research, Inc., Los Angeles, California, United States of America.
Frasco MA; Consolidated Research, Inc., Los Angeles, California, United States of America.
Cook MB; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
Fraumeni JF Jr; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
Hoover RN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2014 Jan 29; Vol. 9 (1), pp. e85805. Date of Electronic Publication: 2014 Jan 29 (Print Publication: 2014).
Typ publikacji:
Journal Article; Research Support, N.I.H., Intramural
MeSH Terms:
Myocardial Infarction/*chemically induced
Prescription Drugs/*adverse effects
Testosterone/*adverse effects
Age Factors ; Aged ; Carbolines/adverse effects ; Humans ; Male ; Middle Aged ; Phosphodiesterase 5 Inhibitors/adverse effects ; Piperazines/adverse effects ; Purines/adverse effects ; Risk ; Sildenafil Citrate ; Sulfones/adverse effects ; Tadalafil
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Physical activity and sedentary behavior in relation to esophageal and gastric cancers in the NIH-AARP cohort.
Autorzy:
Cook MB; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
Matthews CE; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
Gunja MZ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
Abid Z; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
Freedman ND; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
Abnet CC; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2013 Dec 19; Vol. 8 (12), pp. e84805. Date of Electronic Publication: 2013 Dec 19 (Print Publication: 2013).
Typ publikacji:
Journal Article
MeSH Terms:
Sedentary Behavior*
Esophageal Neoplasms/*epidemiology
Esophageal Neoplasms/*etiology
Motor Activity/*physiology
Stomach Neoplasms/*epidemiology
Stomach Neoplasms/*etiology
Age Factors ; Body Mass Index ; Cohort Studies ; Humans ; Proportional Hazards Models ; Risk Factors ; Surveys and Questionnaires ; United States/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Regional variations in esophageal cancer rates by census region in the United States, 1999-2008.
Autorzy:
Drahos J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America. />Wu M
Anderson WF
Trivers KF
King J
Rosenberg PS
Eheman C
Cook MB
Pokaż więcej
Źródło:
PloS one [PLoS One] 2013 Jul 04; Vol. 8 (7), pp. e67913. Date of Electronic Publication: 2013 Jul 04 (Print Publication: 2013).
Typ publikacji:
Journal Article; Research Support, N.I.H., Intramural
MeSH Terms:
Censuses*
SEER Program*
Adenocarcinoma/*epidemiology
Carcinoma, Squamous Cell/*epidemiology
Esophageal Neoplasms/*epidemiology
Aged ; Aged, 80 and over ; Esophageal Squamous Cell Carcinoma ; Female ; Humans ; Incidence ; Male ; Middle Aged ; Midwestern United States/epidemiology ; New England/epidemiology ; Northwestern United States/epidemiology ; Sex Factors ; Southeastern United States/epidemiology ; White People
SCR Disease Name:
Adenocarcinoma Of Esophagus
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 33

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies